Publicaciones en colaboración con investigadores/as de University of Cambridge (12)

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-25

2018

  1. Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer

    Cell Death and Differentiation, Vol. 25, Núm. 5, pp. 828-840

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival

    British Journal of Cancer, Vol. 115, Núm. 2, pp. 212-222

2013

  1. The role of GPR55 in cancer

    endoCANNABINOIDS: Actions at Non-CB1/CB2 Cannabinoid Receptors (Springer New York), pp. 115-133

2012

  1. Cannabinoids: A new hope for breast cancer therapy?

    Cancer Treatment Reviews, Vol. 38, Núm. 7, pp. 911-918

  2. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

    Oncogene, Vol. 30, Núm. 2, pp. 245-252

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9

  2. The putative cannabinoid receptor GPR55 participates in the control of cancer cell proliferation

    EJC SUPPLEMENTS